- 10:17 PM Where do economists' see Q2 GDP headed?
- 10:04 PM Revealed: Exposure of Indian realty cos to Dubai m...
- 09:59 PM Dubai debt crisis just a trigger, 4500 Nifty key: ...
- 09:16 PM Dubai crisis confirms undue leverage fears: Roubin...
- 08:26 PM Patni promoters to set up a VC fund: Sources
- 08:21 PM November 28-30: Events to watch out for
- 07:27 PM Barclays Bk, Calyon Bk move Bombay HC against Wock...
- 07:17 PM Nirmal Bang's after market report
- 07:13 PM Prestige Group to file DRHP soon: Sources
- 07:11 PM Karnataka govt approves Mittal's Rs 30K cr steel p...



Treatment for obesity traditionally involves diet therapy and lifestyle modifications such as physical exercise. However, conventional therapies alone are not always sufficient in achieving desired weight loss, as they have their own limitations. The decreased food intake may lead to nutritional deficiencies and the obese may find it difficult to strictly follow the diet regimen. Hence these difficulties in long-term weight management are encouraging patients to look for more effective treatment options with guaranteed results.
Emerging anti-obesity treatment therapies such as pharmacotherapy, bariatric surgeries, as well as the use of weight loss devices will help meet the rising need to reduce the prevalence of obesity and its associated health risks.
If you are interested in a virtual brochure, which provides manufacturers, end users, and other industry participants with an overview of the latest analysis on Clinical Management of Obesity, then send an e-mail to Shwetha Thomas/ Samantha Unnikrishnan, Corporate Communications, at sthomas@frost.com / sunnikrishnan@frost.com with your full name, company name, title, telephone number, e-mail address, city, state, and country. We will send you the overview by e-mail upon receipt of the above information.
“Pharmacotherapy, is an Food and Drug Administration (FDA) approved treatment for patients who have not responded to diet therapy and physical exercises,” states Frost & Sullivan Research Analyst Sangeetha Prabakar. “It is recommended, both, for obese individuals with a body mass index (BMI) of 30+ who do not have any associated health risks such as type 2 diabetes, heart disease, hypertension, and stroke in addition to moderately obese patients with two or more collateral conditions.”
Contd on page 2....
Business
Business News | Economy | Earnings | BSE NSE Notices
General News
Current Affairs | Politics | World News | Sports | Entertainment
Corporate Strategy
Management | Advertising | Marketing | Legal
Personal Finance
Tax | Insurance | Credit Cards | Loans | Property | Retirement | Investment Help | Financial Planning | Fixed Income
Markets
Local Market | Global Market | Market Cues | Analysis | Expert & FII outlook | Brokerage Recomendation
Stocks
Stocks in News | Expert Advice | ADRs & GDRs | IPO
Mutual Funds
News | Advice | MF Analysis | Fund Managers Views
Lifestyle
Travel | Wellness | Technology | Auto| Books
-
Most Read
-
Most Viewed
- 10 Companies that FIIs love
- Dubai crisis: Which Indian companies may be affected
- 10 companies that MF managers love
- Dubai jitters: Will bears overtake investor confidence now?
- Global mkts panic on Dubai's debt rescheduling
- Indian mkts rattled from Dubai default impact

- Mkts singe in Dubai crisis, end down despite smart recovery
- Ganeshaspeaks: Market prediction for Nov 27
- Should you stop picking stocks?
- Ashwani Gujral's top five picks for today's trade

- China`s 50-year bond
Source: ft.com
- Lanco Infra tying up funds for three power projects
Source: Business Line
- RIL units to get 20% of gas needs from D-6
Source: Business Line
- No need to ban cotton export, says Maran
Source: Business Line










